Home
About
Corporate Mission
Leadership
Scientific & Clinical Advisors
Medical Advisory Board (AC5)
Products
Ordering Information
Intellectual Property
AC5 Advanced Wound System
Technology
Platform
Preclinical Data
Clinical Data
Pipeline
Pipeline Opportunity
Investors
Investor Relations
IR Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Documents
Contact
Home
Investors
News
Press Releases
Investors
Overview
News
Press Releases
IR Calendar
Presentations
Interviews
Stock Data
SEC Filings
Corporate Governance
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
02/21/17
Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
02/16/17
Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5(TM)
02/8/17
Arch Therapeutics to Provide Corporate Updates at Two Conferences in New York, February 2017
02/2/17
Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics
01/23/17
Arch Therapeutics to Present at Noble Financial Capital Markets' Thirteenth Annual Equity Conference
01/5/17
Arch Therapeutics to Present at The Biotech Showcase(TM) 2017 Conference on January 10th, 2017
12/5/16
Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016
10/31/16
Arch Therapeutics Reports AC5 Topical Hemostatic Device Successfully Stopped Bleeding in Patients on Antiplatelet Therapy in Recently Completed Clinical Study
10/11/16
Arch Therapeutics Will Present at the 2016 Bio Investor Forum in San Francisco, California October 18-19th, 2016
09/15/16
Arch Therapeutics Will Present at the 2016 Aegis Capital Growth Conference in Las Vegas, NV September 20-22, 2016
<< Previous
1...
5
6
7
8
9
10
11
12
13
14
Next >>
Show All